HANIEH ROKNI: Open Payments
NPI 1962112284 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 35 payments from 11 companies in 2025. Trend: 2023 $1,311 · 2024 $704 · 2025 $1,068
Food & beverage: $1,068
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $264 |
| GENZYME CORPORATION | 5 | $192 |
| E.R. Squibb & Sons, L.L.C. | 3 | $155 |
| Janssen Biotech, Inc. | 3 | $84 |
| Arcutis Biotherapeutics, Inc. | 4 | $80 |
| Biofrontera Inc. | 4 | $78 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $64 |
| Madrigal Pharmaceuticals | 2 | $49 |
| ABBVIE INC. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
Products named: Opzelura, DUPIXENT, Sotyktu, TREMFYA, Zoryve, REZDIFFRA, ILUMYA, SKYRIZI.
Industry payments across NY — which companies pay providers there.
